Bioequivalence standards for generic drugs have long ignored batch-to-batch variability, risking false conclusions. New guidelines now require multi-batch testing to ensure real-world equivalence and patient safety.
Apr, 1 2026
Jan, 18 2026
Dec, 22 2025
Nov, 22 2025
Dec, 1 2025